Patents Assigned to Schering Akitiengesellschaft
  • Patent number: 6225297
    Abstract: This invention relates to a combination product that consists of individual dosage units of a competitive progesterone antagonist and, in addition, sequentially provided individual dosage units of a compound with gestagenic action, as well as its use for the production of contraceptives based on the inhibition of implantation (receptivity inhibition).
    Type: Grant
    Filed: November 1, 1996
    Date of Patent: May 1, 2001
    Assignee: Schering Akitiengesellschaft
    Inventors: Klaus Stockemann, Kristof Chwalisz